Cargando…
Blood based biomarkers for movement disorders
Movement disorders have been carefully clinically defined, based on clinico‐pathological series; however there is often diagnostic and prognostic uncertainty, especially in early stage disease. Blood‐based biomarkers for Alzheimer's disease (AD), particularly p‐tau181 and p‐tau217, may be usefu...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828103/ https://www.ncbi.nlm.nih.gov/pubmed/36156206 http://dx.doi.org/10.1111/ane.13700 |